PETCO HEALTH AND WELLNESS CO
WOOFNASDAQ🏆 #2201 by market capEarnings Aug 26US Equity
$2.74▲ $0.06 (+2.24%)
🌅 Pre-market$2.81▲ 2.51%Regular close · extended-hours price shown1h—
24h▲ 2.2%
7d▼ 6.5%
14d▼ 2.5%
30d▲ 5.8%
1y▼ 20.7%
🏦Market Cap
$886M
Small Cap
📈Revenue Growth (YoY)
-1.9%
Declining
📊Gross Margin
38.7%
Healthy
💵FCF Margin
3.9%
Moderate
⚖️P/S Ratio
0.1x
Cheap
Otter Score
64
Fair
📊
Analyst Ratings
Price
$2.74
Total
25
Raised
5
Lowered
6
Avg PT
$3.46
H / L
$4 / $2
| Institution | Action | Rating | Date |
|---|---|---|---|
Citigroup | Reiterated | Neutral | 2026-06-04 |
Evercore ISI Group | Reiterated | In Line | 2026-06-04 |
UBS | Reiterated | Neutral | 2026-03-16 |
Jefferies | Upgraded | Hold → Buy | 2026-03-12 |
RBC Capital | Reiterated | Outperform | 2025-09-03 |
Guggenheim | Reiterated | Neutral | 2025-09-02 |
Baird | Reiterated | Neutral | 2025-08-29 |
Wells Fargo | Reiterated | Equal Weight | 2025-08-29 |
Morgan Stanley | Reiterated | Equal Weight | 2025-06-06 |
Goldman Sachs | Reiterated | Buy | 2025-03-27 |
Wedbush | Reiterated | Outperform | 2025-03-27 |
Needham | Reiterated | Buy | 2024-05-23 |
B of A Securities | Downgraded | Buy → Underperform | 2024-04-02 |
Gordon Haskett | Reiterated | Hold | 2023-04-28 |
Credit Suisse | Upgraded | Neutral → Outperform | 2021-08-20 |
BNP Paribas | Reiterated | Underperform | 2021-07-16 |
Benchmark | Downgraded | Buy → Hold | 2017-02-09 |
CL King | Downgraded | Buy → Neutral | 2017-01-25 |
Raymond James | Downgraded | Strong Buy → Market Perform | 2017-01-09 |
William Blair | Upgraded | Market Perform → Outperform | 2016-01-20 |
Stifel | Reiterated | Buy | 2015-07-29 |
GARP Research | Downgraded | Buy → Neutral | 2014-06-03 |
Piper Sandler | Upgraded | Neutral → Overweight | 2013-07-25 |
Northcoast Research | Upgraded | Neutral → Buy | 2013-06-03 |
Barrington Research | Downgraded | Outperform → Market Perform | 2013-05-19 |
One row per institution, most recent rating